vitamin b13
Trade name: Orotic acid
Small moleculeexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2005 (NCT00227058)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- CUBNAGONIST
PID1 agonist
Chemistry & pharmacology
Loading structure…
SMILES
O=C(O)c1cc(=O)[nH]c(=O)[nH]1- Mol. weight
- 156.1 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL1235017 ↗
Also known as
- 6-uracilcarboxylic acid
- orotic acid
- orotic acid
- orotic acid
- orotic acid
- orotic acid
- orotic acid
- orotic acid
- orotic acid
- orotonin
- oroturic
- orotyl
- vitamin b13
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01620268 | Phase 2 | Jul 1, 2012 | Chang Zheng Hospital, Cinkate Corp |
| NCT00227058 | N/A | Jan 1, 2005 | Kyowa Hakko Kogyo, University of Mississippi |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chang Zheng Hospital | Academic/Hospital | 1 | 1 | 1 | 2012 |
| Cinkate Corp | For profit | 1 | 0 | 1 | 2012 |
| Kyowa Hakko Kogyo | For profit | 1 | 0 | 1 | 2005 |
| University of Mississippi | Academic/Hospital | 1 | 1 | 1 | 2005 |
4 organizations
Page 1 / 1